NCT01087645 A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01084928 A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians Status COMPLETED Phase NA
NCT01080157 Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes Status COMPLETED Phase N/A
NCT01079234 Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01078103 Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II Status COMPLETED Phase N/A
NCT01077570 An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients Status COMPLETED Phase N/A
NCT01076647 Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01076634 Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01074268 Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01073137 Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions Status UNKNOWN Phase N/A
NCT01068678 Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01068665 Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01068652 Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs Status COMPLETED Phase PHASE4
NCT01065948 A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours Status COMPLETED Phase PHASE1
NCT01065155 Relationship of Central Blood Pressure and Pulse Wave Velocity With Target Organ Damage Status COMPLETED Phase N/A
NCT01059812 A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3